Gettysburg Cancer Center, with clinics in Gettysburg and Hanover, PA, will join OneOncology, the national platform for independent community oncology practices, OneOncology announced.
Gettysburg, PA and Nashville, TN – June 21, 2021 -- Gettysburg Cancer Center (GCC), with clinics in Gettysburg and Hanover, PA, will join OneOncology, the national platform for independent community oncology practices, OneOncology announced today. By joining OneOncology, Gettysburg Cancer Center will remain independent and have the capital, technology and expertise to grow into the premier cancer care provider in Pennsylvania.
Gettysburg Cancer Center is led by Satish Shah, MD, who has practiced in the community for more than 25 years and run more than 100 clinical trials throughout his career.
Gettysburg Cancer Center offers patients comprehensive medical and radiation oncology care, including a robust clinical trial program. GCC currently has 17 patients enrolled in 14 open clinical trials. As part of the OneOncology partnership, GCC will join OneR, OneOncology’s clinical trial network. OneR will enhance GCC’s clinical trial program with scale and resources to bring additional innovative therapies to patients in Pennsylvania.
“OneOncology gives us the best path forward to continue to bring our patients in Central Pennsylvania advanced cancer care and to grow our clinical trial program,” said Satish Shah, MD. “Working with other leading oncology practices across the country who share our vision for delivering the highest quality care in the community setting is what sets OneOncology apart.”
GCC currently has three medical oncologists, one radiation oncologist and four full-time staff dedicated to clinical research. In advance of going live on the platform, OneOncology’s physician recruitment team has already grown the number of providers on staff by adding an additional medical oncologist, radiation oncologist and two advanced practice providers, all of whom will start this fall.
GCC’s expansion plans include offering additional services along the continuum of cancer care in their Gettysburg and Hanover clinics as well as bringing additional independent oncology practices into GCC and onto the OneOncology platform.
“Gettysburg Cancer Center is known as a leading clinical practice, making them a perfect fit for OneOncology,” said Jeff Patton, MD, CEO, OneOncology. “We look forward to bringing resources and expertise to our colleagues at GCC to help the practice grow and provide additional services along the continuum of cancer care for their patients.”
With the addition of GCC, there are now more than 600 providers on the OneOncology platform caring for approximately 280,000 patients annually at 189 sites of care across the country.
Clinical Trials and New Techniques Advance the Bladder Cancer Treatment Landscape
May 31st 2023For Bladder Cancer Awareness Month, Jahan Aghalar, MD, discussed the latest advancements in treating patients with bladder cancer along with which targets have helped to push the field forward.
Read More
New Technologies, Holistic Treatment Approaches for Brain Cancer Emerging
May 17th 2023For Brain Cancer Awareness Month, Charles Redfern, MD, discussed the biggest technological changes to treatment for adult patients with brain cancer and how holistic treatment remains important for treating this challenging disease.
Read More
Gettysburg Cancer Center Expands Clinical Trial Resources With Help of OneOncology
August 9th 2021In an interview with Targeted Oncology™, Statish Shah, MD, the medical director of Gettysburg Cancer Center, discusses the OneOncology partnership in more detail and how it will benefit patients.
Read More